VJHemOnc is committed to improving our service to you

iwCLL 2019 | Signal-omics to fingerprint the impact of antigen engagement in CLL

VJHemOnc is committed to improving our service to you

Adam Linley

Adam Linley, PhD, University of Liverpool, Liverpool, UK, gives us an overview of his study of signal-omics to fingerprint the impact of antigen engagement and therapy on BCR activation in chronic lymphocytic leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter